February 2024
1. WATSON K
   A Physician Attack on the FDA - Will the Supreme Court Reduce Access to Mifepristone?
   N Engl J Med. 2024;390:563-567.
   

   >> Share

   
   November 2023
2. LEE CD, Nappi RE, Cwiak C
   Oral Contraceptives for Menstrual Migraine with Aura.
   N Engl J Med. 2023;389:2102-2104.
   

   >> Share

   
   October 2023
3. ROBERTSON C, Braman A
   The New Over-the-Counter Oral Contraceptive Pill - Assessing Financial Barriers to Access.
   N Engl J Med. 2023;389:1352-1354.
   

   >> Share

   
   February 2022
4. ZETTLER PJ, Sarpatwari A
   State Restrictions on Mifepristone Access - The Case for Federal Preemption.
   N Engl J Med. 2022;386:705-707.
   

   >> Share

   
   January 2022
5. SCHUMMERS L, Darling EK, Dunn S, McGrail K, et al
   Abortion Safety and Use with Normally Prescribed Mifepristone in Canada.
   N Engl J Med. 2022;386:57-67.
   

   >> Share

   
   June 2021
6. FOX D, Cole E
   The Supreme Court's Abortion Exceptionalism - Judicial Deference, Medical Science, and Mifepristone Access.
   N Engl J Med. 2021;384:e94.
   

   >> Share

   
   February 2021
7. AL-HENDY A, Lukes AS, Poindexter AN 3rd, Venturella R, et al
   Treatment of Uterine Fibroid Symptoms with Relugolix Combination Therapy.
   N Engl J Med. 2021;384:630-642.
   

   >> Share

   
   January 2021
8. TUROK DK, Gero A, Simmons RG, Kaiser JE, et al
   Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception.
   N Engl J Med. 2021;384:335-344.
   

   >> Share

   
   September 2020
9. RASMUSSEN SA, Lyerly AD, Jamieson DJ
   Delaying Pregnancy during a Public Health Crisis - Examining Public Health Recommendations for Covid-19 and Beyond.
   N Engl J Med. 2020 Sep 30. doi: 10.1056/NEJMp2027940.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share